Frontiers Career Development Awards and Investigator Development Awards are funded by the ACCP Research Institute.
|
2008
|
ACCP Frontiers Career Development
|
Sony Tuteja
|
|
2008
|
ACCP Frontiers Career Development
|
S. Casey Laizure
|
|
2008
|
ACCP Investigator Development
|
Robert J. DiDomenico
|
|
2008
|
ACCP Investigator Development
|
Kelly C. Lee
|
|
2007
|
ACCP Frontiers Career Development
|
Christina Aquilante
|
|
2007
|
ACCP Frontiers Career Development
|
Jennifer Cocohoba
|
|
2007
|
ACCP Frontiers Career Development
|
Hyunyoung Jeong
|
|
2007
|
ACCP Frontiers Career Development
|
Wendy Klein-Schwartz
|
|
2007
|
ACCP Frontiers Career Development
|
Brian Overholser
|
|
2007
|
ACCP Frontiers Career Development
|
Daniel Wermeling
|
|
2007
|
ACCP Frontiers Career Development
|
Issam Zineh
|
|
2007
|
Nephrology(Amgen)
|
Mariann Churchwell
|
|
2007
|
Anemia(Watson)
|
Cynthia Jackevicius
|
|
2007
|
Hematology/Oncology(Amgen)
|
Ty Heath Kiser
|
|
2007
|
Pharmacotherapy(ACCP)
|
Jennifer Le
|
|
2007
|
Health Outcomes (Astra Zeneca)
|
Ludmila Bakhireva
|
|
2006
|
ACCP Frontiers Career Development
|
Amber L. Beitelshees
|
|
2006
|
ACCP Frontiers Career Development
|
Jeffrey Bishop
|
|
2006
|
ACCP Frontiers Career Development
|
Larisa Cavallari
|
|
2006
|
ACCP Frontiers Career Development
|
Elizabeth Hermsen
|
|
2006
|
ACCP Frontiers Career Development
|
Robert MacLaren
|
|
2006
|
ACCP Frontiers Career Development
|
James Tisdale
|
|
2006
|
ACCP Frontiers Career Development
|
Annie Wong-Beringer
|
|
2006
|
ACCP Pharmacotherapy
|
David Feola
|
|
2006
|
Amgen Hematology/Oncology
|
Jody Lyn Grabinski
|
|
2006
|
Amgen Nephrology
|
Sheryl Chow
|
|
2006
|
AstraZeneca Cardiovascular
|
Orly Vardeny
|
|
2006
|
AstraZeneca Health Outcomes
|
Tracy Taveira
|
|
2006
|
Sanofi-Aventis CNS
|
Jeffrey Bishop
|
|
2006
|
Sanofi-Aventis Health Services
|
Jean-Venable Goode
|
|
2006
|
Sanofi-Aventis Thrombosis
|
Nathan Clark
|
|
2006
|
TAP Pharmaceutical Products GI
|
David Foster
|
|
2006
|
Watson Labs Anemia
|
Amy Pai
|
|
2005
|
ACCP Career Development
|
Marianne McCollum
|
|
2005
|
ACCP Frontiers Award
|
Donald Brophy
|
|
2005
|
ACCP Frontiers Award
|
Christine Ruby
|
|
2005
|
ACCP Frontiers Award (+ Kos Dyslipidemia)
|
Kari Olson
|
|
2005
|
ACCP Frontiers Award
|
Judith Smith
|
|
2005
|
ACCP Frontiers Award (+ Sanofi-Aventis Allergy/Asthma)
|
Hengameh Raissy
|
|
2005
|
ACCP Frontiers Award
|
Curtis Haas
|
|
2005
|
ACCP Frontiers Award
|
Lingtak-Neander Chan
|
|
2005
|
ACCP Pharmacotherapy
|
Tawny Bettinger
|
|
2005
|
Amgen Hematology/Oncology
|
Robert Dicenzo
|
|
2005
|
Amgen Nephrology
|
Stacy Shord
|
|
2005
|
AstraZeneca Cardiovascular
|
Brian Overholser
|
|
2005
|
AstraZeneca Health Outcomes
|
Jessica Milchak
|
|
2005
|
Kos Dyslipidemia (+ Frontiers Award)
|
Kari Olson
|
|
2005
|
Sanofi-Aventis Allergy/Asthma (+Frontiers Award)
|
Hengameh Raissy
|
|
2005
|
Sanofi-Aventis CNS
|
Susie Park
|
|
2005
|
Sanofi-Aventis ID
|
Nathan Wiederhold
|
|
2005
|
Sanofi-Aventis Thrombosis
|
James Kalus
|
|
2005
|
TAP GI
|
Brian Neudeck
|
|
2005
|
TAP Women’s Health
|
Annie Cheang
|
|
2005
|
Watson Anemia
|
Joanna Hudson
|
|
2004
|
ACCP Career Development
|
Daren L. Knoell
|
|
2004
|
ACCP Frontiers Award
|
Sean Hennessy
|
|
2004
|
ACCP Frontiers Award
|
Melanie S. Joy
|
|
2004
|
ACCP Frontiers Award (+ Amgen Nephrology)
|
Thomas Charles Dowling
|
|
2004
|
ACCP Frontiers Award
|
Mary T. Roth
|
|
2004
|
ACCP Pharmacotherapy
|
Christina L. Aquilante
|
|
2004
|
Amgen Hematology/Oncology
|
Scott Alan McConnell
|
|
2004
|
Amgen Nephrology
|
Thomas Charles Dowling
|
|
2004
|
AstraZeneca Cardiovascular
|
John M. Dopp
|
|
2004
|
AstraZeneca Health Outcomes
|
Marianne McCollum
|
|
2004
|
Aventis Infectious Diseases
|
Amanda Harris Corbett
|
|
2004
|
Bayer Pharmaceuticals Infectious Diseases
|
G. Christopher Wood
|
|
2004
|
Kos Dyslipidemia
|
Issam Zineh
|
|
2004
|
Roche Labs Transplantation
|
Pamela C. Heaton
|
|
2004
|
Sanofi-Synthelabo Central Nervous System
|
Darcie-Ann D. Streetman
|
|
2004
|
Sanofi-Synthelabo Thrombosis
|
Jeremy D. Flynn
|
|
2003
|
ACCP Career Development
|
Paul M. Beringer
|
|
2003
|
ACCP Pharmacotherapy
|
Judith Ann Smith
|
|
2003
|
AstraZeneca Cardiovascular
|
James P. Tsikouris
|
|
2003
|
AstraZeneca Health Outcomes
|
Craig Coleman
|
|
2003
|
Aventis Asthma/Allergy
|
Mary Jayne Kennedy
|
|
2003
|
Aventis Infectious Diseases
|
Phillip David Rogers
|
|
2003
|
Bayer Infectious Diseases
|
Brent M. Booker
|
|
2003
|
Ortho Biotech Pharmacogenomics
|
Scott Penzak
|
|
2003
|
Roche Labs Transplantation
|
Thomas C. Dowling
|
|
2003
|
Tap Pharma Gastrointestinal
|
David R. Foster
|
|
2003
|
Watson Laboratories Anemia
|
Amy Barton Pai
|
|
2002
|
ACCP Career Development
|
Mary Hayney
|
|
2002
|
ACCP Pharmacotherapy
|
Brien Neudeck
|
|
2002
|
Amgen Biotechnology
|
Joanna Hudson
|
|
2002
|
Amgen Biotechnology
|
Sandra Kane
|
|
2002
|
Aventis Asthma/Allergy
|
Francoise Pradel
|
|
2002
|
Aventis Cardiovascular
|
James Nawarskas
|
|
2002
|
Aventis Infectious Diseases
|
P. David Rodgers
|
|
2002
|
AstraZeneca Cardiovascular
|
Thomas Lenz
|
|
2002
|
Pharmacia Health Outcomes
|
Gary Cochran
|
|
2002
|
Roche Transplantation
|
Melanie Joy
|
|
2002
|
Wyeth Women’s Health
|
Kai Annie Cheang
|
|
2001
|
ACCP Pharmacotherapy
|
Curtis Haas
|
|
2001
|
Amgen Biotechnology
|
Mary S. Hayney
|
|
2001
|
Amgen Oncology
|
Shewan Aziz
|
|
2001
|
Amgen Oncology
|
Jill Kolesar
|
|
2001
|
AstraZeneca Cardiovascular
|
Tien Ng
|
|
2001
|
Aventis Asthma/Allergy
|
Kim Adcock
|
|
2001
|
Aventis Cardiovascular
|
J. Jason Sims
|
|
2001
|
Aventis Infectious Diseases
|
Jeffrey Aeschlimann
|
|
2001
|
Pharmacia Applied Health Outcomes
|
Laura L. Dupuis
|
|
2001
|
Roche Laboratories Transplantation
|
Yi-Min (Julie) Ku
|
|
2001
|
TAP Pharmaceuticals
|
Brien L. Neudeck
|
|
2001
|
Wyeth-Ayerst Women’s Healthcare
|
Lynda S. Welage
|
|
2001
|
Wyeth Women’s Health
|
Kai Annie Cheang
|
|
2000
|
ACCP Pharmacotherapy
|
Stanley W. Carson
|
|
2000
|
Amgen Biotechnology
|
Philip D. Hall
|
|
2000
|
Amgen Oncology
|
Susan Goodin
|
|
2000
|
AstraZeneca Psychiatry
|
Vicki Ellingrod
|
|
2000
|
Aventis Asthma/Allergy
|
Rose Jung
|
|
2000
|
Aventis Cardiovascular
|
Robert B. Parker
|
|
2000
|
Aventis Infectious Diseases
|
P. David Rogers
|
|
2000
|
Wyeth-Ayerst Women’s Healthcare
|
Mary E. Elliott
|
|
1999
|
Amgen Biotechnology
|
Mary S. Hayney
|
|
1999
|
Amgen Biotechnology
|
David P. Nicolau
|
|
1999
|
Bristol-Myers Squibb CNS
|
Mark S. Luer
|
|
1999
|
Bristol-Myers Squibb Primary Care
|
Joseph Saseen
|
|
1999
|
GlaxoWellcome Pharmacotherapy
|
Robert A. Blouin
|
|
1999
|
Pharmacia & Upjohn APO
|
Dong-Churl Suh
|
|
1999
|
Rhone-Poulenc Rorer Cardiovascular
|
James E. Tisdale
|
|
1999
|
Rhone-Poulenc Rorer Oncology
|
William C. Zamboni
|
|
1999
|
Rhone-Poulenc Rorer Pulmonary
|
Michael J. Asmus
|
|
1999
|
Wyeth-Ayerst Lab Women’s Healthcare
|
Bettina A. Hamelin
|
|
1999
|
Zeneca Psychiatry
|
Vicki Ellingrod
|
|
1998
|
Amgen Biotechnology
|
Mary S. Hayney
|
|
1998
|
Bayer Infectious Diseases
|
Angela D. Kashuba
|
|
1998
|
Bristol-Myers Squibb CNS
|
Denise H. Rhoney
|
|
1998
|
Bristol-Myers Squibb Primary Care
|
Patricia Marshik
|
|
1998
|
GlaxoWellcome Pharmacotherapy
|
Paul O. Gubbins
|
|
1998
|
Pharmacia & Upjohn APO
|
Marie A. Chisholm
|
|
1998
|
Rhone-Poulenc Rorer Cardiovascular
|
Bradley G. Phillips
|
|
1998
|
Rhone-Poulenc Rorer Oncology
|
Jill Kolesar
|
|
1998
|
Rhone-Poulenc Rorer Pulmonary
|
Sandra S. Garner
|
|
1998
|
Wyeth-Ayerst Women’s Healthcare
|
Kevin M. Sowinski
|
|
1997
|
Amgen Biotechnology
|
Nancy Lamb
|
|
1997
|
Amgen Biotechnology
|
Stephen C. Piscitelli
|
|
1997
|
Bristol-Myers Squibb CNS
|
Mark S. Luer
|
|
1997
|
Bristol-Myers Squibb Family Medicine
|
Elena M. Wildasin/Umland
|
|
1997
|
GlaxoWellcome Pharmacotherapy
|
Kevin Sowinski
|
|
1997
|
Pharmacia & Upjohn Pharmacoeconomics
|
Jeffrey A. Johnson
|
|
1997
|
Rhone-Poulenc Rorer Cardiovascular
|
FChantel Pharand
|
|
1997
|
Rhone-Poulenc Rorer Oncology
|
Carla L. Van Den Berg
|
|
1997
|
Rhone-Poulenc Rorer Pulmonary
|
Diane M. Cappelletty
|
|
1997
|
Wyeth-Ayerst Women’s Healthcare
|
Joseph S. Bertino
|
|
1996
|
Amgen Biotechnology
|
John G. Kuhn
|
|
1996
|
Amgen Biotechnology
|
Kathleen A. Stringer
|
|
1996
|
Bristol-Myers Squibb CNS
|
Patricia D. Kroboth
|
|
1996
|
Bristol Myers Squibb Family Medicine
|
David W. Bartels
|
|
1996
|
Chiron Oncology
|
Peter W. Kazakoff
|
|
1996
|
GlaxoWellcome Pharmacotherapy
|
Sally Usdin Yasuda
|
|
1996
|
Ortho-McNeil Infectious Diseases
|
Christopher J. Destache
|
|
1996
|
Pharmacia & UpJohn Pharmacoeconomics
|
Karen Blumenschein
|
|
1996
|
Rhone-Poulenc Rorer Cardiovascular
|
Jacqueline Marinac
|
|
1996
|
Rhone-Poulenc Rorer Oncology
|
Howard L. McLeod
|
|
1996
|
Rhone-Poulenc Rorer Pulmonary
|
George R. Dickens
|
|
1996
|
Wyeth-Ayerst Women’s Healthcare
|
Aaron H. Burstein
|
|
1995
|
Amgen Biotechnology
|
Gerald Higa
|
|
1995
|
Bristol-Myers Squibb CNS
|
Susan C. Fagan
|
|
1995
|
Bristol-Myers Squibb Family Medicine
|
Allan J. Ellsworth
|
|
1995
|
Chiron Oncology
|
William J. McIntyre
|
|
1995
|
Robert Wood Johnson Infectious Diseases
|
Michael Ujhelyi
|
|
1995
|
Rhone-Poulenc Rorer Cardiovascular
|
Patrick L. McCollam
|
|
1995
|
Rhone-Poulenc Rorer Oncology
|
Alan L. Lau
|
|
1995
|
Rhone-Poulenc Rorer Pulmonary
|
Ralph Lugo
|
|
1995
|
UpJohn Pharmacoeconomics
|
Wendy L. St. Peter
|
|
1995
|
Wyeth-Ayerst Women’s Healthcare
|
Reginald Frye
|
|
1994
|
Amgen Biotechnology
|
Daren L. Knoell
|
|
1994
|
Bristol-Myers Squibb CNS
|
Bettina A. Hamelin
|
|
1994
|
Bristol-Myers Squibb Family Medicine
|
Eric F. Schneider
|
|
1994
|
Chiron Therapeutics Oncology
|
Timothy R. McGuire
|
|
1994
|
Glaxo Pharmacotherapy
|
Arasb Ateshkadi
|
|
1994
|
Robert Wood Johnson Infectious Diseases
|
Stephen C. Piscitelli
|
|
1994
|
Rhone-Poulenc Rorer Cardiovascular
|
Robert B. Parker
|
|
1994
|
Rhone-Poulenc Rorer Oncology
|
Francis Y.W. Lam
|
|
1994
|
Rhone-Poulenc Rorer Pulmonary
|
Mary H.H. Chandler
|
|
1994
|
Upjohn Pharmacoeconomics
|
Kathleen Bungay
|
|
1993
|
Amgen Biotechnology
|
Jimmi Hatton
|
|
1993
|
Bristol-Myers Squibb CNS
|
Stanley W. Carson
|
|
1993
|
Cetus Oncology
|
Carla L. Van Den Berg
|
|
1993
|
Glaxo Pharmacotherapy
|
Reina Bendayan
|
|
1993
|
Mead Johnson Family Medicine
|
Anne Hume
|
|
1993
|
Robert Wood Johnson Infectious Diseases
|
John D. Cleary
|
|
1993
|
Rhone-Poulenc Rorer Respiratory
|
Eric Hoie
|
|
1993
|
Rhone-Poulenc Rorer Respiratory
|
Kjel Johnson
|
|
1993
|
UpJohn Pharmacoeconomics
|
Jeffrey L. McVey
|
|
1992
|
Amgen Biotechnology
|
Daniel P. Healy
|
|
1992
|
Cetus Cancer Immunotherapy
|
Phillip D. Hall
|
|
1992
|
Glaxo Pharmacotherapy
|
Colin G. Adir
|
|
1992
|
Mead Johnson CNS
|
Kristen K. Flaherty
|
|
1992
|
Mead Johnson Family Medicine
|
Andrea D. Van Slooten
|
|
1992
|
Rhone-Poulenc Rorer Respiratory
|
Mary H.H. Chandler
|
|
1992
|
UpJohn Pharmacoeconomics
|
Lisa A. Sanchez
|
|
1991
|
Amgen Biotechnology
|
Christine M. Kearns
|
|
1991
|
Glaxo Pharmacotherapy
|
Barry E. Bleske
|
|
1991
|
Mead Johnson CNS
|
Jimmi Hatton
|
|
1991
|
Mead Johnson Family Medicine
|
Lucinda G. Miller
|
|
1991
|
UpJohn Pharmacoeconomics
|
Douglas N. Fish
|
|
1990
|
Amgen Biotechnology
|
William F. Petros
|
|
1990
|
Cetus Cancer Immunotherapy
|
Joseph A. Tammi
|
|
1990
|
Glaxo Pharmacotherapy
|
Lawrence J. Hak
|
|
1990
|
Key Hypertension
|
Julie A. Johnson
|
|
1990
|
Mead Johnson CNS
|
Susan C. Fagan
|
|
1990
|
Mead Johnson Family Medicine
|
Barry L. Carter
|
|
1990
|
UpJohn Pharmacoeconomics
|
Steven Barriere
|
|
1989
|
Glaxo Pharmacotherapy
|
G. Dennis Clifton
|
|
1989
|
Mead Johnson CNS
|
M. Lynn Crismon
|
|
1989
|
UpJohn Innovative Clinical Practice
|
Maryann S. Reynolds Restino
|
|
1989
|
UpJohn Pharmacoeconomics
|
Roger S. Sommi
|
|
1988
|
Glaxo
|
Robert J. Straka
|
|
1988
|
Mead Johnson CNS
|
Candace S. Brown
|
|
1988
|
UpJohn Innovative Clinical Practice
|
Mary H.H. Chandler
|
|
1988
|
UpJohn Pharmacoeconomics
|
Curtis D. Black
|
|
1987
|
Glaxo
|
David R. Rutledge
|
|
1987
|
Mead Johnson
|
Judith S. Saklad
|
|
1986
|
Mead Johnson CNS
|
Bradley Boucher
|